Old Web
English
Sign In
Acemap
>
authorDetail
>
Angel Fowler Taylor
Angel Fowler Taylor
Novartis
Medicine
COPD
Anesthesia
Indacaterol
Adverse effect
4
Papers
681
Citations
0.01
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Long-Term Maintenance Bronchodilation With Indacaterol/Glycopyrrolate Versus Indacaterol in Moderate-to-Severe COPD Patients: The FLIGHT 3 Study
2016
Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation
Gary T. Ferguson
Angel Fowler Taylor
Chau Thach
Qian Wang
Agnes Annette Schubert-Tennigkeit
Francesco Patalano
Donald Banerji
Show All
Source
Cite
Save
Citations (11)
QVA149 versus glycopyrronium for COPD – Authors' reply
2013
The Lancet Respiratory Medicine
Jadwiga A. Wedzicha
Marc Decramer
Joachim H. Ficker
Dennis E. Niewoehner
Thomas Sandström
Angel Fowler Taylor
Peter D’Andrea
Christie Arrasate
Hungta Chen
Donald Banerji
Show All
Source
Cite
Save
Citations (1)
Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group study
2013
The Lancet Respiratory Medicine
Jadwiga A. Wedzicha
Marc Decramer
Joachim H. Ficker
Dennis E. Niewoehner
Thomas Sandström
Angel Fowler Taylor
Peter D’Andrea
Christie Arrasate
Hungta Chen
Donald Banerji
Show All
Source
Cite
Save
Citations (411)
Omalizumab for the treatment of exacerbations in children with inadequately controlled allergic (IgE-mediated) asthma.
2009
The Journal of Allergy and Clinical Immunology
Bob Lanier
Tracy Bridges
Marek Kulus
Angel Fowler Taylor
I Berhane
Carlos Fernandez Vidaurre
Show All
Source
Cite
Save
Citations (258)
1